Compare MSCI & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MSCI | GEHC |
|---|---|---|
| Founded | 1998 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Computer Software: Prepackaged Software |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.6B | 38.9B |
| IPO Year | 2007 | N/A |
| Metric | MSCI | GEHC |
|---|---|---|
| Price | $584.17 | $78.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 11 |
| Target Price | ★ $645.13 | $88.27 |
| AVG Volume (30 Days) | 440.7K | ★ 2.9M |
| Earning Date | 01-28-2026 | 02-04-2026 |
| Dividend Yield | ★ 1.20% | 0.17% |
| EPS Growth | 3.54 | ★ 32.35 |
| EPS | ★ 15.77 | 4.83 |
| Revenue | $3,055,440,000.00 | ★ $20,246,000,000.00 |
| Revenue This Year | $11.90 | $6.33 |
| Revenue Next Year | $9.32 | $4.32 |
| P/E Ratio | $38.20 | ★ $16.92 |
| Revenue Growth | ★ 9.02 | 3.51 |
| 52 Week Low | $486.74 | $57.65 |
| 52 Week High | $634.99 | $94.80 |
| Indicator | MSCI | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 53.53 | 37.59 |
| Support Level | $575.23 | $84.59 |
| Resistance Level | $605.62 | $87.60 |
| Average True Range (ATR) | 12.91 | 2.24 |
| MACD | 0.86 | -0.82 |
| Stochastic Oscillator | 55.78 | 5.06 |
MSCI has described its mission as enabling investors to build better portfolios for a better world. MSCI's largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. MSCI boasts about $17 trillion in benchmarked assets, including over $2.2 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. In its sustainability and climate segment, MSCI provides ESG data to the investment industry. In private assets, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).